1921
Volume 101, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

A negative interferon-γ release assay (IGRA) result might inappropriately lower the clinical suspicion for childhood tuberculosis (TB) and result in delayed treatment initiation. However, the risk factors associated with false-negative IGRA results in children remain unclear. Between May 2012 and January 2018, 156 culture-confirmed childhood TB patients who had received T-SPOT.TB test were included. Data, including demographic information and clinicopathological variables, were collected via questionnaires. Univariate and multivariate logistic regression analyses were performed to estimate the odds ratio (OR) and corresponding 95% CI of risk factors associated with false-negative T-SPOT.TB results. The positive rate of T-SPOT.TB test was 85.9% in childhood TB patients. Multivariate analysis revealed that younger age (≤ 9 years; OR = 4.782; 95% CI: 1.689, 13.539), weight for age (-score > 0.37; OR = 4.256; 95% CI: 1.458, 12.428), and hypoproteinemia (total protein ≤ 68.4 g/L; OR = 7.131; 95% CI: 1.864, 27.271) were risk factors for false-negative T-SPOT.TB results in childhood TB. Younger age, overweight, and hypoproteinemia were found to be associated with false-negative T-SPOT.TB results in childhood TB. Health care professionals should consider these risk factors when evaluating suspected childhood TB with negative T-SPOT.TB results.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.18-0684
2019-10-28
2020-10-29
Loading full text...

Full text loading...

/deliver/fulltext/14761645/101/6/tpmd180684.html?itemId=/content/journals/10.4269/ajtmh.18-0684&mimeType=html&fmt=ahah

References

  1. Tao NN, He XC, Zhang XX, Liu Y, Yu CB, Li HC, 2017. Drug-resistant tuberculosis among children, China, 2006–2015. Emerg Infect Dis 23: 18001805.
    [Google Scholar]
  2. Mazurek GH, Jereb JA, Vernon A, LoBue P, Goldberg S, Castro KG; IGRA Expert Committee; Centers for Disease Control and Prevention (CDC), 2010. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection, United States, 2010. MMWR Recomm Rep 59: 125.
    [Google Scholar]
  3. He Y, Zhang W, Huang T, Wang X, Wang M, 2015. Evaluation of a diagnostic flow chart applying medical thoracoscopy, adenosine deaminase and T-SPOT.TB in diagnosis of tuberculous pleural effusion. Eur Rev Med Pharmacol Sci 19: 35633568.
    [Google Scholar]
  4. Chen Q, Guo X, Wang X, Wang M, 2016. T-SPOT.TB in detection of active tuberculosis during pregnancy: a retrospective study in China. Med Sci Monit 22: 5760.
    [Google Scholar]
  5. Park SY, Jeon K, Um SW, Kwon OJ, Kang ES, Koh WJ, 2009. Clinical utility of the QuantiFERON-TB Gold In-Tube test for the diagnosis of active pulmonary tuberculosis. Scand J Infect Dis 41: 818822.
    [Google Scholar]
  6. Nguyen DT, Teeter LD, Graves J, Graviss EA, 2018. Characteristics associated with negative interferon-gamma release assay results in culture-confirmed tuberculosis patients, Texas, USA, 2013–2015. Emerg Infect Dis 24: 534540.
    [Google Scholar]
  7. Di L, Li Y, 2018. The risk factor of false-negative and false-positive for T-SPOT.TB in active tuberculosis. J Clin Lab Anal 32: e22273.
    [Google Scholar]
  8. Pan L et al., 2015. Risk factors for false-negative T-SPOT.TB assay results in patients with pulmonary and extra-pulmonary TB. J Infect 70: 367380.
    [Google Scholar]
  9. Lee YM, Park KH, Kim SM, Park SJ, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH, 2013. Risk factors for false-negative results of T-SPOT.TB and tuberculin skin test in extrapulmonary tuberculosis. Infection 41: 10891095.
    [Google Scholar]
  10. Arend SM, Geluk A, van Meijgaarden KE, van Dissel JT, Theisen M, Andersen P, Ottenhoff TH, 2000. Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides. Infect Immun 68: 33143321.
    [Google Scholar]
  11. Lian G, Du F, Wu H, He M, Liu Z, 2017. Factors contributing to false-negative enzyme-linked immunospot assay for interferon-gamma results in active tuberculosis. Clin Lab 63: 773779.
    [Google Scholar]
  12. Kwon YS, Kim YH, Jeon K, Jeong BH, Ryu YJ, Choi JC, Kim HC, Koh WJ, 2015. Factors that predict negative results of QuantiFERON-TB Gold In-Tube test in patients with culture-confirmed tuberculosis: a multicenter retrospective cohort study. PLoS One 10: e0129792.
    [Google Scholar]
  13. Kobashi Y, Shimizu H, Ohue Y, Mouri K, Obase Y, Miyashita N, Oka M, 2009. False negative results of QuantiFERON TB-2G test in patients with active tuberculosis. Jpn J Infect Dis 62: 300302.
    [Google Scholar]
  14. Auld SC, Lee SH, Click ES, Miramontes R, Day CL, Gandhi NR, Heilig CM, 2016. IFN-gamma release assay result is associated with disease site and death in active tuberculosis. Ann Am Thorac Soc 13: 21512158.
    [Google Scholar]
  15. Sharninghausen JC, Shapiro AE, Koelle DM, Kim HN, 2018. Risk factors for indeterminate outcome on interferon gamma release assay in non-US-born persons screened for latent tuberculosis infection. Open Forum Infect Dis 5: ofy184.
    [Google Scholar]
  16. Thomas TA, Mondal D, Noor Z, Liu L, Alam M, Haque R, Banu S, Sun H, Peterson KM, 2010. Malnutrition and helminth infection affect performance of an interferon gamma-release assay. Pediatrics 126: e1522e1529.
    [Google Scholar]
  17. Deng Y, Wang Y, Wang J, Jing H, Yu C, Wang H, Liu Z, Graviss EA, Ma X, 2011. Laboratory-based surveillance of extensively drug-resistant tuberculosis, China. Emerg Infect Dis 17: 495497.
    [Google Scholar]
  18. Shen F, Han C, Wang MS, He Y, 2018. Poor agreement between repeated T-SPOT.TB in a short time period in a high TB burden country. Infect Dis (Lond) 50: 771774.
    [Google Scholar]
  19. Sun L et al., 2011. Interferon gamma release assay in diagnosis of pediatric tuberculosis: a meta-analysis. FEMS Immunol Med Microbiol 63: 165173.
    [Google Scholar]
  20. Lee YJ, Lee J, Kim YY, Won DI, Cha SI, Park JY, Jung TH, Kim CH, 2011. Performance of whole-blood interferon-gamma release assay in patients admitted to the emergency department with pulmonary infiltrates. BMC Infect Dis 11: 107.
    [Google Scholar]
  21. Shaikh N et al., 2017. Novel interferon-gamma assays for diagnosing tuberculosis in young children in India. Int J Tuberc Lung Dis 21: 412419.
    [Google Scholar]
  22. Ferrara G et al., 2006. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 367: 13281334.
    [Google Scholar]
  23. Hang NT et al., 2011. Analysis of factors lowering sensitivity of interferon-gamma release assay for tuberculosis. PLoS One 6: e23806.
    [Google Scholar]
  24. Aabye MG et al., 2012. Negative effect of smoking on the performance of the QuantiFERON TB Gold in tube test. BMC Infect Dis 12: 379.
    [Google Scholar]
  25. Jung HJ et al., 2014. Analysis of predictors influencing indeterminate whole-blood interferon-gamma release assay results in patients with rheumatic diseases. Rheumatol Int 34: 17111720.
    [Google Scholar]
  26. Shu CC, Wu VC, Yang FJ, Pan SC, Lai TS, Wang JY, Wang JT, Lee LN, 2012. Predictors and prevalence of latent tuberculosis infection in patients receiving long-term hemodialysis and peritoneal dialysis. PLoS One 7: e42592.
    [Google Scholar]
  27. Kim EY et al., 2009. Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population. BMC Infect Dis 9: 207.
    [Google Scholar]
  28. Cho K, Cho E, Kwon S, Im S, Sohn I, Song S, Kim H, Kim S, 2012. Factors associated with indeterminate and false negative results of QuantiFERON-TB Gold In-Tube test in active tuberculosis. Tuberc Respir Dis (Seoul) 72: 416425.
    [Google Scholar]
  29. Jeong SJ, Han SH, Kim CO, Baek JH, Jin SJ, Ku NS, Choi JY, Song YG, Kim HS, Kim JM, 2011. Predictive factors for indeterminate result on the QuantiFERON test in an intermediate tuberculosis-burden country. J Infect 62: 347354.
    [Google Scholar]
  30. Kim CH, Lim JK, Yoo SS, Lee SY, Cha SI, Park JY, Lee J, 2014. Diagnostic performance of the QuantiFERON-TB Gold In-Tube assay and factors associated with nonpositive results in patients with miliary tuberculosis. Clin Infect Dis 58: 986989.
    [Google Scholar]
  31. Choi JC, Jarlsberg LG, Grinsdale JA, Osmond DH, Higashi J, Hopewell PC, Kato-Maeda M, 2015. Reduced sensitivity of the QuantiFERON(®) test in diabetic patients with smear-negative tuberculosis. Int J Tuberc Lung Dis 19: 582588.
    [Google Scholar]
  32. Gebreegziabiher D, Desta K, Howe R, Abebe M, 2014. Helminth infection increases the probability of indeterminate QuantiFERON gold in tube results in pregnant women. Biomed Res Int 2014: 364137.
    [Google Scholar]
  33. Li T et al., 2015. Influencial factors of the performance of interferon-gamma release assays in the diagnosis of childhood tuberculosis. Clin Exp Med 15: 303309.
    [Google Scholar]
  34. Liao CH, Lai CC, Tan CK, Chou CH, Hsu HL, Tasi TH, Huang YT, Hsueh PR, 2009. False-negative results by enzyme-linked immunospot assay for interferon-gamma among patients with culture-confirmed tuberculosis. J Infect 59: 421423.
    [Google Scholar]
  35. Banfield S, Pascoe E, Thambiran A, Siafarikas A, Burgner D, 2012. Factors associated with the performance of a blood-based interferon-gamma release assay in diagnosing tuberculosis. PLoS One 7: e38556.
    [Google Scholar]
  36. Critselis E, Amanatidou V, Syridou G, Spyridis NP, Mavrikou M, Papadopoulos NG, Tsolia MN, 2012. The effect of age on whole blood interferon-gamma release assay response among children investigated for latent tuberculosis infection. J Pediatr 161: 632638.
    [Google Scholar]
  37. Jenum S, Selvam S, Mahelai D, Jesuraj N, Cardenas V, Kenneth J, Hesseling AC, Doherty TM, Vaz M, Grewal HM, 2014. Influence of age and nutritional status on the performance of the tuberculin skin test and QuantiFERON-TB Gold In-Tube in young children evaluated for tuberculosis in southern India. Pediatr Infect Dis J 33: e260e269.
    [Google Scholar]
  38. Kampmann B, Tena-Coki G, Anderson S, 2006. Blood tests for diagnosis of tuberculosis. Lancet 368: 282; author reply 282–283.
    [Google Scholar]
  39. Connell TG, Curtis N, Ranganathan SC, Buttery JP, 2006. Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax 61: 616620.
    [Google Scholar]
  40. Womack J, Tien PC, Feldman J, Shin JH, Fennie K, Anastos K, Cohen MH, Bacon MC, Minkoff H, 2007. Obesity and immune cell counts in women. Metabolism 56: 9981004.
    [Google Scholar]
  41. Huang CJ, Zourdos MC, Jo E, Ormsbee MJ, 2013. Influence of physical activity and nutrition on obesity-related immune function. ScientificWorldJournal 2013: 752071.
    [Google Scholar]
  42. Reechaipichitkul W, Pimrin W, Bourpoern J, Prompinij S, Faksri K, 2015. Evaluation of the QuantiFERON®-TB Gold In-Tube assay and tuberculin skin test for the diagnosis of Mycobacterium tuberculosis infection in northeastern Thailand. Asian Pac J Allergy Immunol 33: 236244.
    [Google Scholar]
  43. Gonzalez-Torres C, Gonzalez-Martinez H, Miliar A, Najera O, Graniel J, Firo V, Alvarez C, Bonilla E, Rodriguez L, 2013. Effect of malnutrition on the expression of cytokines involved in Th1 cell differentiation. Nutrients 5: 579593.
    [Google Scholar]
  44. Dai G, McMurray DN, 1998. Altered cytokine production and impaired antimycobacterial immunity in protein-malnourished guinea pigs. Infect Immun 66: 35623568.
    [Google Scholar]
  45. Demissie A, Abebe M, Aseffa A, Rook G, Fletcher H, Zumla A, Weldingh K, Brock I, Andersen P, Doherty TM, 2004. Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2. J Immunol 172: 69386943.
    [Google Scholar]
  46. Redford PS, Boonstra A, Read S, Pitt J, Graham C, Stavropoulos E, Bancroft GJ, O’Garra A, 2010. Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. Eur J Immunol 40: 22002210.
    [Google Scholar]
  47. Almeida AS et al., 2009. Tuberculosis is associated with a down-modulatory lung immune response that impairs Th1-type immunity. J Immunol 183: 718731.
    [Google Scholar]
  48. Chandra RK, 1983. Numerical and functional deficiency in T helper cells in protein energy malnutrition. Clin Exp Immunol 51: 126132.
    [Google Scholar]
  49. Haque R, Mondal D, Shu J, Roy S, Kabir M, Davis AN, Duggal P, Petri WA Jr., 2007. Correlation of interferon-gamma production by peripheral blood mononuclear cells with childhood malnutrition and susceptibility to amebiasis. Am J Trop Med Hyg 76: 340344.
    [Google Scholar]
  50. Takele Y et al., 2016. Malnutrition in healthy individuals results in increased mixed cytokine profiles, altered neutrophil subsets and function. PLoS One 11: e0157919.
    [Google Scholar]
  51. Papay P et al., 2011. Predictors of indeterminate IFN-gamma release assay in screening for latent TB in inflammatory bowel diseases. Eur J Clin Invest 41: 10711076.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.18-0684
Loading
/content/journals/10.4269/ajtmh.18-0684
Loading

Data & Media loading...

  • Received : 20 Aug 2018
  • Accepted : 25 Sep 2019
  • Published online : 28 Oct 2019
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error